Finance

Lists
IPHYF:OTCMKTS
Innate Pharma SA
$1.65
0.00%
(0.00) 1D
May 27, 12:16:39 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for IPHYF...
Mkt. cap
216.46M
Avg. vol.
0.00
Volume
0.00
52-wk high
$2.25
52-wk low
$1.37
Beta
0.78
Shares outstanding
111.72M
No. of employees
164
Mkt. cap
216.46M
Avg. vol.
0.00
Volume
0.00
52-wk high
$2.25
52-wk low
$1.37
Beta
0.78
Shares outstanding
111.72M
No. of employees
164
About Innate Pharma SA
CEO-
Employees164
Founded1999
Headquarters-
SectorBiotechnology
Websiteinnate-pharma.com
Previous reportsAll values in EUR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in EUR
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
2.43M
2.43M
2.07M
2.07M
Cost of goods sold
10.26M
10.26M
11.55M
11.55M
Cost of revenue
10.26M
10.26M
11.55M
11.55M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
4.88M
4.88M
4.81M
4.81M
Operating expense
4.88M
4.88M
4.81M
4.81M
Total operating expenses
15.14M
15.14M
16.36M
16.36M
Operating income
-12.71M
-12.71M
-14.29M
-14.29M
Other non operating income
231.50K
231.50K
144.00K
144.00K
EBT including unusual items
-10.67M
-10.67M
-13.92M
-13.92M
EBT excluding unusual items
-10.67M
-10.67M
-13.92M
-13.92M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-10.67M
-10.67M
-13.92M
-13.92M
Net profit margin
-439.18%
-439.18%
-671.48%
-671.48%
Earnings per share
-
-
-
-
Interest and investment income
396.50K
396.50K
262.50K
262.50K
Interest expense
-114.50K
-114.50K
-105.50K
-105.50K
Net interest expenses
282.00K
282.00K
157.00K
157.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-12.53M
-12.53M
-14.12M
-14.12M
Gain or loss from assets sale
10.00K
10.00K
1.50K
1.50K
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps